NEW YORK, June 8 (GenomeWeb News) - Israel's Chaim Sheba Medical Center has selected PerkinElmer's nenonatal screen technology to create a national newborn screening program, the company said today.
The neonatal screening initiative will be built around the company's AutoDELFIA automatic immunoassay system. PerkinElmer will deliver multiple AutoDELFIA units as well as reagents and equipment.
Under the agreement, PerkinElmer will provide the center with instruments, reagents, scientific expertise, and an informatics system to enhance its neonatal screening and data-management capabilities.
Israel is following a mandate set by the Medical Research Infrastructure Development and Health Services Fund to substantially expand its newborn screening program to cover the entire population and to increase the number of tests screened for indications of disease.